Reporting rates of abnormal uterine bleeding after COVID-19 vaccination in South Korea
Jae Min Lee1, Seung Geun Yeo1,2, Sung Soo Kim3
1Department of Otorhinolaryngology Head & Neck Surgery, College of Medicine, Kyung Hee University Medical Center, Seoul, Republic of Korea.
Introduction:
Abnormal uterine bleeding after COVID-19 vaccination has been reported, but few studies have characterized population-level reporting rates. We evaluated AUB reporting in South Korea.
Methods:
We analyzed suspected adverse reactions reported to the Korea Disease Control and Prevention Agency from 26 February 2021 to 29 June 2023 (week 121). Cases with AUB were identified, and reporting rates were compared across vaccine types and doses.
Results:
During the study period, 135,894,788 doses were administered, with 483,391 suspected adverse reactions (356 per 100,000) and 6,288 AUB reports (4.9 per 100,000). AUB ranked 15th among reported adverse events. Reporting rates varied by manufacturer and dose.
Discussion:
These descriptive pharmacovigilance findings do not estimate incidence or imply causality. Prospective, controlled studies are needed to clarify causal relationships and to inform diagnostic and management protocols for AUB after vaccination.
Related Concept Videos
01:51Vaccinations
02:45Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
01:15Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
01:16Kidney Transplant III: Nursing Management